Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia Infections

Abstract Introduction Stenotrophomonas maltophilia is notable for its rising incidence and multidrug resistance, which complicates treatment. As a result of insufficient clinical studies, the 2024 Infectious Diseases Society of America (IDSA) Guidance on Treating Antimicrobial Resistant Gram-negativ...

Full description

Bibliographic Details

Published in:	Infectious Diseases and Therapy
Main Authors:	Mohammed Al Musawa, Ashlan J. Kunz Coyne, Sara Alosaimy, Kristen Lucas, Melanie Rae Schrack, Justin Andrade, Shelbye R. Herbin, Mark Biagi, Michael Pierce, Kyle C. Molina, Alaina DeKerlegand, Nicholson B. Perkins, Reese Cosimi, Lena Kang-Birken, Madeline A. King, Benjamin M. Pullinger, Leonor M. Rojas, Jeannette Bouchard, Athena L. V. Hobbs, Jazmin Agee, Kaylee E. Caniff, Sean R. Van Helden, Michael P. Veve, Michael J. Rybak
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2025-06-01
Subjects:	Antimicrobial resistance Drug resistance Eravacycline Gram-negative Stenotrophomonas maltophilia
Online Access:	https://doi.org/10.1007/s40121-025-01170-x